The widespread use of β-lactam antimicrobial agents as first-line therapy for the treatment of
serious infections has led to the development of various resistances that have compromised …

Objective: To investigate the prevalence and antibiotic susceptibility pattern of extended-
spectrum β-lactamases (ESBL)-producing Enterobacteriaecae among patients in the United …

Infections with bacteria producing extended-spectrum beta-lactamases (ESBLs) are
increasing across Africa. This study reports on ESBL-producing Enterobacteriaceae as …

Background Antimicrobial resistance is fast becoming a global concern with rapid increases
in multidrug-resistant Gram negative organisms. The prevalence of extended spectrum beta …

Background: Extended-Spectrum β-Lactamase (ESBL) producing Enterobacteriaceae have
become widespread in hospitals and are increasing in community settings where they cause …

Extended spectrum β-lactamases (ESBLs) are a group of enzymes that can hydrolyze a
variety of β-lactams including fourth generation cephalosporins and compromise the efficacy …

Background Nothing is known about the epidemiology and resistance mechanisms of
extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso …

Abstract β-lactamases represent the most common mechanism of β-lactam resistance.
Extended spectrum β-lactamases (ESBLs) represent a major group of β-lactamses currently …

SUMMARY β-Lactam antibiotics have been widely used as therapeutic agents for the past
70 years, resulting in emergence of an abundance of β-lactam-inactivating β-lactamases …

Background Gram-negative ESKAPE bacteria are increasingly implicated in several difficult-
to-treat infections in developed and developing countries. They are listed by the World …